Mary T. Szela, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 15,960 shares at $49.25 ($786K) on 2011-03-31, disclosed to the SEC on 2011-04-01.
Scheduled sale ($786k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.25 | 13,535 | $667K | 84.8% |
| 2 | $49.26 | 2,425 | $119K | 15.2% |
| Total | $49.25 avg | 15,960 | $786K | 100% |
| Filing → |
| TLSI | SELL | 2026-03-20 | $79K | — | Filing → |
| TLSI | BUY | 2026-02-23 | $125K | — | Filing → |
| TLSI | BUY | 2025-01-31 | $52K | — | Filing → |